Altamira Therapeutics LTD. (CYTOF) — 6-K Filings

6-K Filings (11)

• Altamira Therapeutics Files 6-K Report — Aug 29, 2025 Risk: low
  Altamira Therapeutics Ltd. filed a Form 6-K on August 29, 2025, reporting for the period ending June 30, 2025. The company, formerly known as Auris Medical Hold
• Altamira Therapeutics Holds Annual Shareholder Meeting — Jun 11, 2025 Risk: low
  Altamira Therapeutics Ltd. held its Annual General Meeting of Shareholders on June 11, 2025. The filing does not specify the outcomes or resolutions from this m
• Altamira Therapeutics Files May 2025 6-K Report — May 9, 2025 Risk: low
  Altamira Therapeutics Ltd. (formerly Auris Medical Holding Ltd.) filed a Form 6-K on May 9, 2025, reporting as a foreign private issuer. The company, incorporat
• Altamira Therapeutics Ltd. Files 6-K Report — Mar 10, 2025 Risk: low
  Altamira Therapeutics Ltd. filed a Form 6-K on March 10, 2025, reporting its status as a foreign private issuer. The company, formerly known as Auris Medical Ho
• Altamira Therapeutics Files December 2024 6-K Report — Dec 20, 2024 Risk: low
  Altamira Therapeutics Ltd. filed a Form 6-K on December 20, 2024, reporting for the month of December 2024. The company, formerly known as Auris Medical Holding
• Altamira Therapeutics Faces Nasdaq Delisting Risk — Oct 4, 2024 Risk: medium
  Altamira Therapeutics Ltd. received a letter on September 30, 2024, from the Nasdaq Listing Qualifications department regarding its non-compliance with the mini
• Altamira Therapeutics Ltd. Files 6-K Report — Sep 24, 2024 Risk: low
  Altamira Therapeutics Ltd. filed a Form 6-K on September 24, 2024, reporting for the period ending June 30, 2024. The company, formerly known as Auris Medical H
• Altamira Therapeutics Launches Public Offering — Sep 19, 2024 Risk: medium
  On September 17, 2024, Altamira Therapeutics Ltd. initiated a best efforts public offering. The company, formerly known as Auris Medical Holding Ltd., is a phar
• Altamira Therapeutics Files May 2024 6-K Report — May 16, 2024 Risk: low
  Altamira Therapeutics Ltd. filed a Form 6-K on May 16, 2024, reporting information for the month of May 2024. The company, formerly known as Auris Medical Holdi
• Altamira Therapeutics Files Routine 6-K Report — Apr 16, 2024 Risk: low
  Altamira Therapeutics Ltd. filed a Form 6-K on April 16, 2024, reporting as a foreign private issuer. The company, formerly known as Auris Medical Holding Ltd.,
• Altamira Files Pro Forma Financials for Bentrio® Spin-Off — Jan 19, 2024
  Altamira Therapeutics Ltd. (Altamira) filed a 6-K on January 19, 2024, to include unaudited pro forma financial information related to the partial spin-off of i

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX